United Therapeutics Stock
United Therapeutics Stock
United Therapeutics gained 1.310% today.
United Therapeutics is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
As a result the target price of 287 € shows a slightly positive potential of 13.21% compared to the current price of 253.5 € for United Therapeutics.
Pros and Cons of United Therapeutics in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 1.310% | 1.726% | 13.474% | 24.754% | 27.869% | 63.548% | 212.886% |
| Ironwood Pharmaceuticals | 0.850% | 0.000% | -19.048% | -38.342% | -41.667% | -41.089% | - |
| Novocure Ltd | -7.550% | 11.578% | 84.670% | -71.506% | 46.830% | -85.900% | - |
| Iovance Biotherapeutics Inc. | -0.020% | -4.136% | -10.611% | 39.612% | 21.696% | -35.884% | - |
Comments
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $300.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat